Conmed reports Q1 adjusted EPS 79c, consensus 74c

Reports Q1 revenue $312.3M, consensus $306.78M. “2024 is off to a solid start as the quarter delivered our expected top- and bottom-line growth and margin expansion,” commented Curt R. Hartman, CONMED’s Chair of the Board, President, and Chief Executive Officer. “We remain well positioned with a compelling and diverse portfolio to drive continued growth across the markets we serve.”